Solid Carcinoma — Trials

Solid Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

32 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 17
Recruiting: 12
Ph III recruiting: 1
Growth YoY: —
Industry share: 29%
Top sponsor: Memorial Sloan Kettering Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04264975	Utilization of Microbiome as Biomarkers and Therapeutics in Immuno-Oncology	recruiting	N/A	60	Asan Medical CenterOTHER	1	May 22, 2026	clinicaltrials
NCT06051214	Thrombin Generation and Prediction of Thromboembolic Events in Oncology Patients at Risk(THROMBIN)	recruiting	N/A	200	Institut Cancerologie de l'OuestOTHER	1	Feb 17, 2026	clinicaltrials